THERAMAX COLD & FLU RELIEF NASAL SPRAY
- Manufacturer
- THERABIOGEN | COSMEDX SCIENCE, INC
- Effective date
- 2010-10-06
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 02:02:39
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Drug Facts
Active Ingredients Purpose
Camellia Sinensis 3X Cold and Flu Symptom Relief
Sabmucus Nigra 2X Cold and Flu Symptom Relief
Gelsemium sempervirens 6X, 12X 30X Cold and Flu Symptom Relief
Bryonia alba 6X Cold and Flu Symptom Relief
Sulphur 12X Cold and Flu Symptom Relief
OTC - PURPOSE SECTION
Purpose
Cold and flu symptom relief
INDICATIONS & USAGE SECTION
Uses
Relieves old and flu symptoms
Provides relief from upper respiratory symptoms such as nasal and sinus congestion, runny nose, sore throat, sneezing and headache
Also relieves fever, chills and body aches associated with the flu
WARNINGS SECTION
Warnings
For nasal use only
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have
ear, nose or throat sensitivity
susceptible to nose bleeds
OTC - WHEN USING SECTION
When using this product
Avoid contact with eyes. In case of accidental contact with eyes, flush with water and immediately seek professional help.
The use of this container by more than one person may spread infection.
OTC - STOP USE SECTION
Stop use and ask a doctor if symptoms persist
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant of breast feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
For best results, use at the first sign of cold or flu symptoms and continue to use for an additional 48 hours after symptoms subside
Adults and children 6 years of age and older (with adult supervision):
Remove cap and safety clip also see illustration on side carton and insert).
Hold with thumb at bottom of bottle and nozzle between your fingers
Before using the first tie, prime pump by depressing several times.
Place tip of nozzle just past nazal opening (approxiately 1/8").
While inside nasal opening, slightly angle nozzle outward.
Pump one to tw times into each nostril
After application, press lightly on outside of each nostril for about 5 seconds.
Wait at least 30 seconds before blowing nose
Use once every 4 hours
Children under 6 years of age: consult a doctor before use.
INACTIVE INGREDIENT SECTION
Inactive Ingredients
Benzalkonium chloride, glyerin, hydroxyethylcellulose, potassium phosphate monobasic, sodium chloride, sodium phosphate dibasic, water
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Theramax
Take at the first sign of cold or flu symptoms
No known drug interactions
Non-drowsy
No jitters
Non-habit forming
Homeopathic
Satisfaction guaranteed
Store at room temperature 15C-29C (59F-84F)
Product is naturally dark in color
Questions? Comments?call 866-284-9561 or visit us on the web at
www.theramaxrelief. com
Developed and distributed by
Therabiogen, Inc. (OTC: TRAB.OB)
New York, NY 10005
(c) 2008 PRODUCT OF USA
HOMEOPATHIC
Theramax
Cold and flu relief
ZINC FREE
Nasal Spray
Relief of:
Nasal and Sinus Congestion
Runny Nose
Sore Throat
Sneezing
Chills and Fever
0.50 fl oz (15 ml) Homeopathic
TheraMax
DIRECTIONS
1. Remove cap and safety clip
2. Hold with thumb at bottom and nozzle between your fingers
3. Prior to initial use, prime pump by holding it upright and depressing several ties (into a tissue) until the liquid is dispensed
4. Place tip of nozzle just past nasal opening (approximately 1/8")
5. While inside nasal opening, slightly angle nozzle outward, as shown
6. Pump one to two times into each nostril
7. After application, press lightly on the outside of each nostril for about 5 seconds.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Active Ingredients:
Camellia simensis 3X,
Sambucus nigra 2X
Gelsemium sempervirens 6X, 12X, 30X
Bryonica Alba 6X
Sulphur 12X
Note: Prior to using TheraMax Cold and Flu Relief, read the entire package
(c) 2008 Developed and distributed by Therabiogen, Inc. (OTC: TRABE.OB)
New York, NY 10005
PRODUCT OF USA
TheraMax
Cold and Flu Relief
Zinc Free
Nasal Spary
0.50 fl oz (15 ml) Homeopathic
Do not use if tamper resistant seal is broken or missing.
Uses: Relieves cold and flu symptoms. Provides relief from upper respiratory symptoms such as nasal and sinus congestion, runny nose, sore throat, sneezing and headach. Also relieves fever, chills, ad body aches associated with the flu.
Questions or commeents:
Call 866-284-9561
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51445-101-15 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-dabd-8e05-e053-dbdaa90a074a | THERAMAX COLD & FLU RELIEF NASAL SPRAY |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51445-101-15 | THERABIOGEN COLD AND FLU RELIEF NASAL | 1 in 1 BOX | SPRAY | 1 | 3 | |
| 51445-101-15 | THERABIOGEN COLD AND FLU RELIEF NASAL | 15 mL in 1 BOTTLE, SPRAY | SPRAY | 15 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51445-101 | THERABIOGEN COLD AND FLU RELIEF NASAL (CAMELIA SINENSIS, SAMBUCUS NIGRA, GELSEMIUM SEMPERVIRENS, BRYONIA ALBA, SULPHUR) SPRAY [THERABIOGEN] | 3 | Legacy NDC, 2 package rows | 20101007_17704cc5-96f1-4d10-b5f6-252c6491db49.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| BRYONIA ALBA ROOT | ACTIVE INGREDIENT | T7J046YI2B | 3 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE INGREDIENT | 639KR60Q1Q | 3 | |
| GREEN TEA LEAF | ACTIVE INGREDIENT | W2ZU1RY8B0 | 3 | |
| SAMBUCUS NIGRA FLOWERING TOP | ACTIVE INGREDIENT | CT03BSA18U | 3 | |
| SULFUR | ACTIVE INGREDIENT | 70FD1KFU70 | 3 | |
| BRYONIA ALBA ROOT | ACTIVE MOIETY | T7J046YI2B | 3 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE MOIETY | 639KR60Q1Q | 3 | |
| GREEN TEA LEAF | ACTIVE MOIETY | W2ZU1RY8B0 | 3 | |
| SAMBUCUS NIGRA FLOWERING TOP | ACTIVE MOIETY | CT03BSA18U | 3 | |
| SULFUR | ACTIVE MOIETY | 70FD1KFU70 | 3 | |
| BENZALKONIUM CHLORIDE | INACTIVE INGREDIENT | F5UM2KM3W7 | 3 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 3 | |
| POTASSIUM PHOSPHATE, MONOBASIC | INACTIVE INGREDIENT | 4J9FJ0HL51 | 3 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | 3 | |
| SODIUM PHOSPHATE, DIBASIC | INACTIVE INGREDIENT | GR686LBA74 | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Products#
Every source-derived product name is available through these pages.
- THERABIOGEN COLD AND FLU RELIEF NASAL
- CAMELIA SINENSIS, SAMBUCUS NIGRA, GELSEMIUM SEMPERVIRENS, BRYONIA ALBA, SULPHUR
- GREEN TEA LEAF
- SAMBUCUS NIGRA FLOWERING TOP
- GELSEMIUM SEMPERVIRENS ROOT
- BRYONIA ALBA ROOT
- SULFUR
- BENZALKONIUM CHLORIDE
- GLYCERIN
- POTASSIUM PHOSPHATE, MONOBASIC
- SODIUM CHLORIDE
- SODIUM PHOSPHATE, DIBASIC
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 51445-101 | 51445-101-15 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GREEN TEA LEAF | W2ZU1RY8B0 | ACTIB |
| SAMBUCUS NIGRA FLOWERING TOP | CT03BSA18U | ACTIB |
| GELSEMIUM SEMPERVIRENS ROOT | 639KR60Q1Q | ACTIB |
| BRYONIA ALBA ROOT | T7J046YI2B | ACTIB |
| SULFUR | 70FD1KFU70 | ACTIB |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| POTASSIUM PHOSPHATE, MONOBASIC | 4J9FJ0HL51 | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | IACT |
| WATER | 059QF0KO0R | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SUSPENSION / ORAL | 98 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / TOPICAL | 210 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRA-ARTICULAR | 26 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / ORAL | 1126 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / SUBCUTANEOUS | 1486 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | DROPS / OPHTHALMIC | 0.08 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / SUBCUTANEOUS | 0.8 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SUSPENSION/ DROPS / AURICULAR (OTIC) | 0.02 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION / NASAL | 40.46 mg/100ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / TOPICAL | 0.32 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRA-ARTERIAL | 278 mg | ||
| SODIUM PHOSPHATE, DIBASIC | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | CREAM / TOPICAL | 0.1 %w/w | ||
| POTASSIUM PHOSPHATE, MONOBASIC | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | SUSPENSION / OPHTHALMIC | 0.44 %w/w | ||
| POTASSIUM PHOSPHATE, MONOBASIC | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | INJECTION / INTRAVENOUS | 68 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRABURSAL | 9 mg | ||
| SODIUM PHOSPHATE, DIBASIC | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | FILM, SOLUBLE / ORAL | 9 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / DENTAL | 0.4 %w/v | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION / AURICULAR (OTIC) | 0.01 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | 0.86 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PERINEURAL | 648 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRATHECAL | 9 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | OINTMENT / TOPICAL | 0.03 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRAMUSCULAR | 26 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / EPIDURAL | 648 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / TOPICAL | 0.23 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | INJECTION / INTRAMUSCULAR | 1 mg | ||
| SODIUM PHOSPHATE, DIBASIC | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | INJECTION / SUBCUTANEOUS | 14 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / EPIDURAL | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRATHECAL | 131 mg | ||
| POTASSIUM PHOSPHATE, MONOBASIC | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | TABLET / ORAL | 25 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRACAUDAL | 210 mg | ||
| POTASSIUM PHOSPHATE, MONOBASIC | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | SYRUP / ORAL | 19 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INFILTRATION | 648 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAVENOUS | 28773 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAPERITONEAL | 226 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, COATED / ORAL | 54.7 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRALESIONAL | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAMUSCULAR | 90 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 877fc49a-0836-4eba-85bb-c8d4241823c9 | 17704cc5-96f1-4d10-b5f6-252c6491db49 | 2010-10-06 | Warnings | 877fc49a-0836-4eba-85bb-c8d4241823c9 17704cc5-96f1-4d10-b5f6-252c6491db49 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

